THERMO FISHER

Serial Number 86695101
606

Registration Progress

Application Filed
Jul 16, 2015
Under Examination
Jul 19, 2016
Approved for Publication
May 24, 2016
Published for Opposition
May 24, 2016
Registered

Trademark Image

THERMO FISHER

Basic Information

Serial Number
86695101
Filing Date
July 16, 2015
Published for Opposition
May 24, 2016
Abandonment Date
August 19, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 19, 2019
Classes
042

Rights Holder

Thermo Fisher Scientific Inc.

03
Address
81 Wyman Street
Waltham, MA 02454

Ownership History

Thermo Fisher Scientific Inc.

Original Applicant
03
Waltham, MA

Thermo Fisher Scientific Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Alan M. Doernberg

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Aug 19, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 19, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 21, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 19, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 18, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 18, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 18, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 19, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 13, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 11, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 11, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 11, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 19, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 24, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 24, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 4, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 19, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 18, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 18, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 18, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 18, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 15, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 15, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 15, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 23, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 23, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 21, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 22, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 20, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing an on-line computer database featuring scientific and medical research information in the field of genetics; Research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consulting services in the field of cloud computing in the fields of life science; Consulting services in the fields of bioinformatics, namely, the development of software for understanding biological data; Computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; providing online non-downloadable software for the custom design and ordering of assays and reagents; Medical research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Product development for others; Laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Laboratory services, namely, nucleic acid analysis; Scientific research in the field of genetics, namely, gene discovery; Scientific research in the field of genetics, namely, genetic diseases, genomics and gene expression research and development; Research on the subject of pharmaceuticals, namely, pharmacokinetics; Scientific research services in the field of proteomics; Genetic testing and mapping services for scientific purposes, namely, gene identification, gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection; Medical and scientific research; Medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; Technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; Pharmaceutical research services; Providing an on-line searchable database in the field of life science for scientific research purposes; Providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, and genetics; Development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; Medical laboratory services; Research and development for new immunotherapy products for others; Scientific research services; Medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; Scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; Contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Consulting services in the field of contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Electronic storage of data, graphs, images and information in the fields of cloud computing, life science, medical research, scientific research and clinical research
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042